Diagnostic testing

Diagnostic tests identify infection type and guide therapies, enabling clinicians to implement effective antimicrobial stewardship interventions. BD diagnostic platforms reduce the risk of transmission of HAIs, promote fully informed prescribing decisions and enhance clinical outcomes by rapidly identifying major drug-resistant threats identified by the World Health Organization and the U.S. Centers for Disease Control and Prevention.

Accurate patient screening

Reduce the risk of HAIs by utilizing diagnostic platforms that efficiently identify patients colonized with resistant organisms.

  • Automated molecular diagnostic systems
  • Prepared plated media for isolation of selected organisms
  • Automated preparation and screening for plated media

Rapid detection and identification
of infectious agents

Guide therapy and prevent unnecessary antimicrobial use by identifying the bacteria, fungus or virus causing the infection.

  • Point-of-care diagnostic testing
  • Identification systems
  • Automated molecular diagnostic systems
  • Automated culture systems
  • Laboratory automation with microbial imaging applications

Precise susceptibility testing

Optimize the patient treatment plan by determining the specific antimicrobials that inhibit or kill particular bacteria.

  • Automated susceptibility testing systems
  • Antimicrobial susceptibility test discs
  • Automated liquid culture and drug susceptibility testing for tuberculosis